SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1927Where Incyte Went Wrong Way back in 1996, Incyte had promised to become profitaRocketman-6/7/2003
1926Rocketman's latest prognostication. By the way, thanks for digging that up Rocketman-6/7/2003
1925Incyte folks look for MMP-11 substrates as targets for cancer therapy. They shotuck-5/20/2003
19245/5/03 conference call notes 1. 1 q review lowered prices in data base businessoftware salesperson-5/5/2003
1923Not saying that it isn't a decent bet at this level, just that with another nigel bates-4/12/2003
1922Nigel- Thanks for the pointer to Rocketman's post, I think he hit the naiBiotech Jim-4/12/2003
1921Credible ? No idea. Their IP should be worth very good money if they have the pnigel bates-4/12/2003
1920Dak we would do beter as follow 1/ accumulate 2/ announce buyout (which will fadalroi-4/11/2003
1919Anyone think this thing is really credible??? Certainly seems cheap enough for LLCF-4/11/2003
1918From XOMA 10K - <i>On July 9, 1998, XOMA entered into a license agreementnigel bates-3/15/2003
1917<i>why not repurchase convertible debt?</i> Management arrogance. nigel bates-2/20/2003
1916<<(i) still intend to repurchase shares? - - yes (ii) why not repurchase rkrw-2/20/2003
1915bj, a few answers: (i) it looks like they have ~ 125 scientists in drug discovsoftware salesperson-2/20/2003
1914Sales- Thanks for the CC notes, I continue to find them quite useful. If my daBiotech Jim-2/19/2003
19132/19/03 conference call notes 1. 2002 accomplishments 3 small molecule drug disoftware salesperson-2/19/2003
1912>>We recently expanded our strategy to include the discovery and developmemicrocapfun-1/29/2003
1911Diadexus <b>therapeutic </b> deal with MEDX - Message 18505661 andnigel bates-1/29/2003
1910MUNICH, Jan. 21 /PRNewswire-FirstCall/-- Ingenium Pharmaceuticals AG has obtainenigel bates-1/21/2003
1909Look at the bright side. It didn't move its corporate headquarters to Vancoutom pope-12/17/2002
1908<< Good to know that they continue to spend those all dollars wisely. >Spekulatius-12/16/2002
1907<i>We look forward to launching a new graphic look and corporate website nnigel bates-12/16/2002
1906They used to be called "Incyte Pharmaceuticals" then the genomics boomrkrw-12/16/2002
1905WASHINGTON, Dec 10 (Reuters) - DiaDexus Inc., which turns raw gene data into disnigel bates-12/10/2002
1904Another perspective - <i>...And, genomics/proteomics companies are increanigel bates-11/14/2002
1903stefaan, nope. salessoftware salesperson-11/12/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News